An impressive array of Big Pharma backers lined up to ensure Strand Therapeutics has the funding needed to take its mRNA-based solid tumor drug further into the clinic. New Strand supporters that ...
Company to share updates at the AACR and ASGCT annual meetings BOSTON--(BUSINESS WIRE)--Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, ...
The MarketWatch News Department was not involved in the creation of this content. Funding will advance Strand's pipeline and mission to bring targeted, next-generation mRNA therapies to patients First ...
Strand Therapeutics has added to its series A funding from last year, bringing the total to $97 million. The messenger RNA (mRNA) therapeutics company is gearing up to bring its lead drug candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback